AAAAAA
Results:
1-12
|
Results: 12
Authors:
ZALCBERG J
MILLWARD M
BISHOP J
MCKEAGE M
ZIMET A
TONER G
FRIEDLANDER M
BARTER C
RISCHIN D
LORET C
JAMES R
BOUGON N
BERILLE J
Citation: J. Zalcberg et al., PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1948-1953
Authors:
PRINCE HM
MILLWARD MJ
RISCHIN D
BLAKEY D
WOLF M
JANUSCEWICZ H
TONER G
BERTONCELLO I
RICHARDSON G
BRIGGS P
SCARLETT J
GATES P
DALE B
Citation: Hm. Prince et al., REPETITIVE HIGH-DOSE THERAPY WITH IFOSFAMIDE, THIOTEPA AND PACLITAXEL(ITP) WITH BLOOD-CELL (BC) SUPPORT FOR METASTATIC BREAST-CANCER (MBC)- RESULTS OF A PHASE-I STUDY, Experimental hematology, 26(8), 1998, pp. 65-65
Authors:
BISHOP JF
DEWAR J
TONER G
TATTERSALL MH
OLVER I
ACKLAND S
KENNEDY I
GOLDSTEIN D
GURNEY H
WALPOLE E
LEVI J
STEPHENSON J
Citation: Jf. Bishop et al., A RANDOMIZED STUDY OF PACLITAXEL VERSUS CYCLOPHOSPHAMIDE METHOTREXATE/5-FLUOROURACIL/PREDNISONE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 24(5), 1997, pp. 5-9
Authors:
BERTONCELLO I
WILLIAMS B
ROSSI R
TONER G
Citation: I. Bertoncello et al., PROLIFERATION AND DIFFERENTIATION OF SINGLE RH HO-DULL STEM-CELLS GROWN IN COCKTAILS OF EARLY ACTING AND LINEAGE RESTRICTED CYTOKINES/, Blood, 90(10), 1997, pp. 3348-3348
Authors:
PRINCE HM
MILLWARD MJ
RISCHIN DR
BLAKEY D
WOLF M
JANUSCEWICZ H
TONER G
RICHARDSON G
SHARKEY P
DALE B
Citation: Hm. Prince et al., REPETITIVE HIGH-DOSE IFOSFAMIDE, THIOTEPA AND PACLITAXEL (ITP) WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT - A NOVEL OUTPATIENT REGIMEN FOR METASTATIC AND LOCALLY ADVANCED BREAST-CANCER, Blood, 90(10), 1997, pp. 4575-4575
Authors:
PHILLIPS KA
SCURRY JP
TONER G
Citation: Ka. Phillips et al., ALPHA-FETOPROTEIN PRODUCTION BY A MALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS, Journal of Clinical Pathology, 49(4), 1996, pp. 349-351
Authors:
ZALCBERG JR
BISHOP JF
MILLWARD MJ
ZIMET A
LAIRD J
BARTER C
SEWARD D
MCKEAGE MJ
FRIEDLANDER ML
TONER G
BERILLE J
BLANC C
Citation: Jr. Zalcberg et al., INTERIM RESULTS OF A PHASE-II TRIAL OF DOCETAXEL IN COMBINATION WITH CISPLATIN IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1084-1084
Authors:
OLVER I
GREEN M
PETERS W
ZIMET A
TONER G
BISHOP J
KETELBEY W
RASTOGI R
BIRKHOFER M
Citation: I. Olver et al., A PHASE-II TRIAL OF ZENIPLATIN IN METASTATIC MELANOMA, American journal of clinical oncology, 18(1), 1995, pp. 56-58
Authors:
JUNEJA S
MATTHEWS J
LUZINAT R
FAN Y
MICHAEL M
RISCHIN D
MILLWARD M
TONER G
Citation: S. Juneja et al., ASSOCIATION OF ACQUIRED PELGER-HUET ANOMALY WITH TAXOID THERAPY, Blood, 86(10), 1995, pp. 2821-2821
Authors:
BISHOP JF
BALL D
CRENNAN E
RYAN G
DAVIS S
TONER G
OBRIEN P
OLVER L
Citation: Jf. Bishop et al., RADIATION AND CARBOPLATIN COMBINED-MODALITY THERAPY IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 21(3), 1994, pp. 91-96
Authors:
DESVEAUX JA
LINDQUIST EA
TONER G
Citation: Ja. Desveaux et al., ORGANIZING FOR POLICY INNOVATION IN PUBLIC BUREAUCRACY - AIDS, ENERGYAND ENVIRONMENTAL-POLICY IN CANADA, Canadian journal of political science, 27(3), 1994, pp. 493-528
Authors:
MAHER DW
LIESCHKE GJ
GREEN M
BISHOP J
STUARTHARRIS R
WOLF M
SHERIDAN WP
KEFFORD RF
CEBON J
OLVER I
MCKENDRICK J
TONER G
BRADSTOCK K
LIESCHKE M
CRUICKSHANK S
TOMITA DK
HOFFMAN EW
FOX RM
MORSTYN G
Citation: Dw. Maher et al., FILGRASTIM IN PATIENTS WITH CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 121(7), 1994, pp. 492-501
Risultati:
1-12
|